Skip to main content
PPN WorldPPN World
Create free account

Shared from the live wire

BioNTech Investor News·DE·

BioNTech Provides Update on Phase 2/3 Clinical Trial for mRNA Cancer Immunotherapy Candidate BNT113 in Metastatic HPV16-positive Head and Neck Cancer

AHEAD-MERIT Phase 2/3 clinical trial did not meet its first dual primary endpoint of progression-free survival for the mRNA cancer immunotherapy candidate BNT113 plus pembrolizumab compared with pembrolizumab alone The trial will continue to evaluate the second dual primary endpoint of overall

Short extract only — this publisher licenses its text. Read the full release at the source.

Create free account →Read at the source ↗

Free plan · Plus CA$29 or Pro CA$99/month

Crossing the wire right now

More from BioNTech Investor News

The rest of this wire is for subscribers

Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.

Create free account →Sign in

Free plan · Plus CA$29 or Pro CA$99/month

This is PPN World

You just read one release. Subscribers see them all — the second they land.

Governments, regulators, central banks, companies and the newswires — in one live screen, searchable, filterable, and watching what you track.

feeds
1,400+
newswires
80+
countries
190+
languages
25+
The PPN World cockpit's live feed, showing government sources in English: the newest official releases, each with its date, time, sector, country and source.

  • 01

    Live, not a digest

    Every release the moment it crosses — no daily email, no 24-hour lag.

  • 02

    Alerts on what you track

    Save a search and know the instant a matching release lands.

  • 03

    The whole archive

    Search back through every release by country, sector, source and language.

Watch

PPN World in 30 seconds

Read the film's text
  1. Embargoed until 07:00:00. Every story starts with an official source.
  2. A company. A government. A regulator. A newswire.
  3. By the time it's news, everyone has it.
  4. Unless you saw it first.
  5. PPN World — the terminal for press releases.
  6. Every press release. One live feed. Deduplicated, translated, streaming the second it's published.
  7. Official information, straight from the source. 1,400+ feeds, 80+ newswires, 190+ countries.
  8. Know what breaks tomorrow. Earnings, elections and official decisions, 14 days ahead.
  9. Alerts. AI briefs. One cockpit. Built for journalists, PR teams and content creators.
  10. Read the wire before it becomes news. ppnworld.com

1,400+ feeds — live on PPN World right now

Don't find out last.

Releases like this one land on PPN World as they are published, from 190+ countries. Read the next one first.

Create free account →

Free plan · Plus CA$29 or Pro CA$99/month

Your announcement next? Distribute your press release to the global wires with PPN Source — and track its pickup live here.

PPN Source →
Shared via PPN World — real-time press release intelligence.